版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、Chapter 38Macrolides, Lincomycins and Polymycins大環(huán)內(nèi)酯類藥物14元大環(huán)內(nèi)酯類:紅霉素、羅紅霉素、克拉霉素、地紅霉素15元大環(huán)內(nèi)酯類:阿奇霉素16元大環(huán)內(nèi)酯類:螺旋霉素、乙酰螺旋霉素、麥迪霉素、麥白霉素、羅他霉素、柱晶白霉素、交沙霉素、米歐卡霉素Macrolides First generation : 1950serythromycinSecond generation:1970sclaithromycin azithromycinThird generation:Common properties of MacrolidesAntibacte
2、rial activityFirst generationMost G+ organisms: pneumococci, streptococci, staphylococci , diphtheriae etcPart G- organisms:legionella軍團(tuán)菌,bacillus pertussis(百日咳), brucella(布氏) etcOthers: mycoplasma(支原體), chlamydia trachomatis(沙眼衣原體), rickettsia(立克次體), spirochete ,anaerobes etc. Second generationMore
3、 active on G- organismsMechanism of actionTarget 50s ribosomal RNAMechanism inhibition of translocation of mRNAMechanism of resistanceProduction of inactivating enzymesModification of the ribosomal binding siteActive efflux systemMLSRPharmokinetics AbsorptionErythromycin: not stable at acid pHNew ma
4、crolides: stable poDistribution Metabolism: Erythromycin&clarithromycin: in liverExcretion Erythromycin& azithromycin: bileClarithromycin: kidneyCommomly used macrolidesErythromycin Antimicrobial activityGram-positive organisms: pneumococci, streptococci, staphylococci , diphtheriae etcGram-negative
5、 organisms:legionella軍團(tuán)菌,bacillus pertussis(百日咳), brucella(布氏) , meningococci, diplococcus gonorrhoeae etcOthers: mycoplasma(支原體), chlamydia trachomatis(沙眼衣原體), rickettsia(立克次體), spirochete ,anaerobes etc. ErythromycinClinical uses As penicillin substitute in penicillin-allergic or resistant patient
6、s with infections caused by staphylococci, streptococci and pneumococciPertussis,diphtheriaeLegionella and mycoplasma pneumoniaH.p infectionErythromycinAdverse reactionsGastrointestinal effectsLiver toxicityCardiotoxicity Erythromycin Erythromycin lactobionate(乳糖酸紅霉素erythromycin estolate無味紅霉素)erythr
7、omycin stearate(硬脂酸紅霉素erythromycin ethylsuccinate琥乙紅霉素, 利君沙 New macrolides antibioticsAdvantage :Broader spectrum, higher activityOrally effectiveHigh blood concentrationLonger t 1/2Less toxicityMainly used in respiratory tract infectionClarithromycin甲紅霉素,克拉霉素Has the strongest activity on Gram-posit
8、ive bacteria, legionella pneumophila, chlamydia pneumoniaeGood pharmacokinetic propertyLow toxicityAzithromycin (阿齊霉素,麗珠奇樂Has the strongest activity against mycoplasma pneumoniae肺炎支原體More effective on Gram-negative bacteriaWell toleratedT1/2 :3548h once dailyMainly used in respitory tract infectionR
9、oxithromycin 羅紅霉素,嚴(yán)迪 1987 FranceThe highest blood concentration F 72%85%Respiratory tract infection and soft tissue infectionLow adverse effectsLincomycin and ClindamycinAntimicrobial activityGram-positive organismsBacteroide fragilis and other anaerobesMechanism Binding to 50s ribosome subunit and
10、inhibiting protein synthesisPharmacokineticsAbsorbed wellPenetrate well into most tissues including bone ClindaycinClinical uses Severe anaerobic infection Acute or chronical suppurative osteomylitis , arthritis caused by susceptive organisms especially Staphylococci aureusAdverse reactionsGastroint
11、estinal effects: severe diarrhea and pseudomembranous enterocolitis caused by Clostridium difficile :vancomycin & metronidazoleOther :Impaired liver function , neutropeniaPolypeptide antibioticsVancomycin & TeicoplaninPolymyxinsbactitracinVancomycin Mechanism of actionInhibit cell wall synthesisAnti
12、microbial spectrum:Narrow spectrum, active only against gram-positive bacteria paticularly staphylococciPharmacokineticsPoorly absorbed from intestinal tract, ivExcreted from glomerular filtration 90%VancomycinClinical uses Infection caused by MRSA, MRSE and penicillin-resistant pneumococcusTreatmen
13、t of antibiotic-associated enterocolitis caused by clostridium difficile poAdverse reactionOtotoxicity & nephrotoxicityRed-man syndromeTeicoplanin Similar to vancomycin in mechanism and antimicrobial spectrumCan be given im as well as ivLess adverse reactionsPolymyxins Active only against gram-negative rods, particularly P.aeruginosaMechanism:increase permeability of cell membraneMainly used in P.aeruginosa infection when other dr
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 克羅恩病的護(hù)理診斷
- 試驗(yàn)室安全教育培訓(xùn)
- 寒號鳥課件2教學(xué)課件
- 3-2-2 物質(zhì)的量在化學(xué)方程式計(jì)算中的應(yīng)用 課件 高一上學(xué)期化學(xué)人教版(2019)必修第一冊
- 腦轉(zhuǎn)移瘤目前治療策略
- 糖尿病前期指導(dǎo)
- 年終合同管理總結(jié)
- 保護(hù)我的耳朵教案及反思小班
- 荷花淀說課稿
- 漢教學(xué)說課稿
- 第13講 教學(xué)設(shè)計(jì)的ASSURE模式(V5.1)公開課一等獎省優(yōu)質(zhì)課大賽獲獎?wù)n件
- 三年級上冊美術(shù)課件-3.色彩的變化|贛美版 (共19張PPT)
- 上海高中語文課文目錄
- 理想與前途主題班會課件
- 顏色標(biāo)準(zhǔn)LAB值對照表
- 甲骨文專題‖精選課件
- 汽修廠危險(xiǎn)源辨識與風(fēng)險(xiǎn)控制制度
- 教科版科學(xué)五年級上冊《用水計(jì)量時(shí)間》學(xué)習(xí)任務(wù)單
- 藍(lán)色商務(wù)極簡科技風(fēng)創(chuàng)新發(fā)布會ppt模板
- 2022-2033年度秋學(xué)期四年級語文上冊教學(xué)進(jìn)度表
- 管理學(xué)原理第5章案例:沙漠求生游戲課件
評論
0/150
提交評論